References
- Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, . Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–5.
- Horwitz EM, Gordon PL, Koo WKK, Marx JC, Neel MD, McNall RY, . Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932–7.
- Chamberlain JR, Schwarze U, Wang P, Hirata RK, Hankenson KD, Pace JM, . Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science.2004;303:1198–201.
- Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, . Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005;11:389–98.
- Lee ST, Jang JH, Cheong J, Kim JS, Maemg H, Hahn JS, . Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol. 2002;118:1128–31.
- Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, . Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–8.
- Chen S, Fang W, Ye F, Liu Y, Qian J, Shan JS, . Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004; 94:92–5.
- De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44:1928–42.
- Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235–42.
- Tsai M, Lee J, Chang Y, Hwang S. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004;19:1450–6.
- In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GMJS, Claas FHJ, Fibbe W, . Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338–45.
- Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, . Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279–95.
- Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (HADAS) cells. Stem Cells. 2005;23:412–23.
- Saulnier N, Lattanzi W, Puglisi MA, Pani G, Barba M, Piscaglia AC, . Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage. Eur Rev Med Pharmacol Sci. 2009;13(Suppl 1):71–8.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(t)) method. Methods. 2001;25:402–8.
- De Boer J, Wang HJ, Van Blitterswijk C. Effects of wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng. 2004;10:393–401.
- Etheridge SL, Spencer GJ, Heath DJ, Genever PG. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells. 2004;22:849–60.
- Neth P, Ciccarella M, Egea V, Hoelters J, Jochum M, Ries C. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells. 2006;24:1892–903.
- He XC, Zhang J, Tong W, Tawfik O, Ross J, Scoville DH, . Bmp signaling inhibits intestinal stem cell self-renewal through suppression of wnt-beta-catenin signaling. Nat Genet. 2004;36:1117–21.
- Jian H, Shen X, Liu I, Semenov M, He X, Wang XF. Smad3-dependent nuclear translocation of beta-catenin is required for tgf-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 2006;20: 666–74.
- Li Y, McClintick J, Zhong L, Edenberg HJ, Yoder MC, Chan RJ. Murine embryonic stem cell differentiation is promoted by socs-3 and inhibited by the zinc finger transcription factor klf4. Blood. 2005;105:635–7.
- Nakatake Y, Fukui N, Iwamatsu Y, Masui S, Takahashi K, Yagi R, . Klf4 cooperates with oct3/4 and sox2 to activate the lefty1 core promoter in embryonic stem cells. Mol Cell Biol. 2006;26:7772–82.
- Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131: 861–72.
- Bruce SJ, Gardiner BB, Burke LJ, Gongora MM, Grimmond SM, Perkins AC. Dynamic transcription programs during ES cell differentiation towards mesoderm in serum versus serum-free BMP4 culture. BMC Genomics. 2007;8:365.
- Jiang J, Chan Y, Loh Y, Cai J, Tong G, Lim CA, . A core KLF circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol. 2008;10:353–60.
- Katoh Y, Katoh M. Conserved POU-binding site linked to SP1-binding site within FZD5 promoter: transcriptional mechanisms of FZD5 in undifferentiated human ES cells, fetal liver/spleen, adult colon, pancreatic islet, and diffuse-type gastric cancer. Int J Oncol. 2007;30:751–5.
- Ellenrieder V. TGFbeta regulated gene expression by SMADs and SP1/KLF-like transcription factors in cancer. Anticancer Res. 2008;28:1531–9.